ArticleCancer research communications2022

A Phase IB Trial of the PI3K Inhibitor Alpelisib and Weekly Cisplatin in Patients with Solid Tumor Malignancies.

Erica S Tsang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.